Tag: R&D

Research and development (R&D or R+D), also known in Europe as research and technical (or technological) development (RTD), is a general term for activities in connection with corporate or governmental innovation. Research and development is situated at the front end of the innovation life cycle, which may end with commercialization.

French startup gained €14.5 million for development of new immunomodulators

lab research
Step Pharma announced the closing of a Series A financing totalling €14.5 million

Boehringer Ingelheim launched open-access platform for scientists

boehringer ingelheim
Boehringer Ingelheim announced the launch of a platform offering free and open access to selected pre-clinical molecules

GEROPHARM is the first in Russia to conduct clamp studies of insulin biosimilars

GEROPHARM research center located in Strelna Special Economic Zone is engaged in a full cycle of advanced insulin drugs development

Eurofins enhances its CDMO capacities

test tubes
Eurofins Scientific recently enhanced its leadership in biopharmaceutical services and expanded its Contract Development and Manufacturing offering

British company developed a solution for antimicrobial resistance problem

microbiology plates
Helperby Therapeutics have developed a novel answer to the clear and present danger of antimicrobial resistance - Antibiotic Resistance Breakers

Abzena and Enleofen Bio develop first-in-class pulmonary fibrosis drugs

lab research
Abzena plc, the life sciences group, works with Enleofen Bio to develop first-in-class antibody therapeutics for the treatment of fibrotic human diseases

Novartis and Homology Medicines started R&D collaboration

Homology Medicines announced today that it entered into a research and development collaboration with Novartis

Schrodinger and ShanghaiTech University join forces for research projects

Schrödinger, Inc. and ShanghaiTech University have reached an agreement to develop a strategic partnership and establish the Shanghai Center of Excellence

Boehringer Ingelheim and Dicerna started a research collaboration

Boehringer Ingelheim and Dicerna Pharmaceuticals announced a research collaboration and license agreement to discover and develop novel RNAi therapeutics

Kymera Therapeutics pioneers a novel drug discovery platform

lab research
Kymera Therapeutics announced a $30M Series A Financing round to advance a transformational new therapeutic modality and discover breakthrough medicines

Bristol-Myers Squibb joined ORIEN Avatar Research Program

M2Gen announced that Bristol-Myers Squibb Company has joined the Oncology Research Information Exchange Network® Avatar Research Program

BioMed X and Janssen will cooperate on biomedical research projects

The BioMed X Innovation Center announced today a collaboration agreement with Janssen Research & Development to foster early-stage preclinical biomedical research and development projects

Center for Preclinical and Translational Research opened in St. Petersburg

The working visit of the Russian Minister of Health to Saint-Petersburg was marked by the opening of the Center for Preclinical and Translational Research

Microsoft and PAREXEL created technology development alliance

Microsoft and PAREXEL International announced a technology development alliance aimed at driving innovation across the life sciences industry

Brazilian pharmaceutical company will open its facility in Ontario

The Government of Ontario is partnering with Biolab Pharma Ltd. to help the company retrofit its first international facility outside Brazil

Primer Capital and Bayer become partners to support biotech startups

Primer Capital, a venture capital biotech fund, and Bayer have signed an agreement on the joint work to identify and develop the promising startups